Breast cancer is one of the leading causes of death in the female population worldwide.
Standard treatments such as chemotherapy show noticeable results. However, along with …

Breast cancer remains a leading global cause of morbidity and mortality. While the field of
immunotherapy is a promising avenue of investigation and has revolutionized the standard …

Breast cancer (BC) is generally classified based on the receptors overexpressed on the cell
nucleus, which include hormone receptors such as progesterone (PR) and estrogen (ER) …

Breast cancer (BC) is a heterogeneous disease characterized by complex physiological
activities such as apoptosis and cell signaling. Non-vesicular drug delivery systems, such as …

Breast cancer is a significant concern for many women, and local chemotherapy has
emerged as a promising approach to address this issue. This study focuses on simulating …

In spite of remarkable improvements in cancer treatments and survivorship, cancer still
remains as one of the major causes of death worldwide. Although current standards of care …

Breast cancer, one of the most common types of cancer worldwide, has a high degree of
malignancy while lacking efficient treatments. The off‐target events frequently occurring in …

Breast cancer (BC) is one of the most common malignant cancers among women and the
second leading cause of cancer-related deaths. Conventional treatments for BC are …

Background: Delivery of chemotherapeutic drugs for the diagnosis and treatment of cancer
is becoming advanced day by day. However, the challenge of the effective delivery system …

Abstract The World Health Organization (WHO) reported that of all the non-communicable
diseases, cancer is considered the second cause of death worldwide. This has driven the …